Table of Contents

    Topic review

    Polyphenols Nano Formulations

    Subjects: Biochemistry
    View times: 51
    Submitted by: Farid Menaa


    Polyphenols are phytochemical with potent antioxidant and antiinflammatory activities which are tremendously of important to fight premature aging, infections, cancers and other related chronic inflammatory diseases. Nanoencapsulation of these natural and functional biocompounds is useful to increase the bioavailability and efficiency of polyphenols, which can be further used as adjuvant therapeutics.

    1. Introduction 

    Plants represent a source of important products with nutritional and therapeutic value, such as polyphenols.

    Polyphenols represent a superfamily of various naturally occurring phytochemicals (>4000), and are abundant micronutrients in our diet (e.g., vegetables, fruits, flowers, nuts, seeds). [1][2] These plant-derived compounds are divided into several classes (e.g., flavonoids, stilbenes, and lignans) and subclasses (e.g., in the case of flavonoids: anthocyanins, proanthocyanidins, flavonols, flavones, flavanols, flavanones, isoflavones).[1][2][3]

    The chemical structure, molecular mechanism, metabolism, plant source and content of various dietary polyphenols have been reviewed elsewhere. [1][2][4][5] Importantly, the preventive and protective health effects exerted by polyphenols as nutraceuticals depend not only on the dietary intake/dose administration but also on their molecular interactions and systemic bioavailability (i.e., time-dependent absorption and metabolism). [1][2][4][5][6] Therefore, the most abundant polyphenols in our diet are not necessarily those that have the best bioavailability profile. Indeed, the bioavailability of polyphenols is widely variable (i.e., about 10-fold variations in the plasmatic total metabolites after intake of 50 mg aglycone equivalents). [4] For instance, gallic acid, along with isoflavones, is far better absorbed than other polyphenols (Cmax values: about 4 μmol/L at ~1.5 hours; mean relative urinary excretion: 38%) while proanthocyanidins and anthocyanins, along with galloylated tea catechins, are among the poorest absorbed polyphenols (Cmax: ~0.025 μmol/L at ~1.5 hours; mean relative urinary excretion: B0.4%). [4] Overall, the bioavailability of dietary polyphenols is known to mainly depend on: [1][2][3] (1) their intestinal absorption, during which the microflora of each given individual plays an important role in the metabolism of polyphenols (i.e., half-lives of active metabolites), (2) their chemical structure (e.g., glycosylation, esterification, and polymerization), (3) their inclusion in the food matrix, and (4) their excretion back into the intestinal lumen.

    There is emerging evidence, based on a number of intervention studies, that topical application (e.g., as cosmetics) and/or oral intake (e.g., as diet supplements) of some polyphenol-rich plant extracts can reduce a number of degenerative diseases and other skin conditions connected to cumulative oxidative injury (e.g., skin cancers, skin photoaging). [3][7][8][9] Due to their recognized anti-inflammatory, antioxidant and DNA repair properties, topically applied polyphenols may also favorably supplement sunscreen protection and other modalities (e.g., esthetic techniques such as microdermabrasion, skin cancer drugs). [3][7][9][10] Essentially, controlled topical application of polyphenols presents an advantage, over the oral or intravenous intake, for maximizing the local exposure and decreasing the systemic toxicity (i.e., serious side effects due to harmed normal cells by high, repeated or chronic doses). [11]

    In recent years, nanoparticulate drug delivery systems using liposomes, biodegradable polymers, dendrimers, virus nanoparticles and magnetic nanoparticles, have attracted increasing attention. [12][13] Some of the most commonly used methods to characterize the nanoparticles have been previously depicted, and the most noticeable nanotechnological applications in medicine have been related to oncology. [13][14][15] Over the past decade, considerable advances have been made in the development of nanoscale therapeutics (i.e., bio-compatible and biodegradable nano-carriers, usually of 1100 nm in size) for controlled drug delivery and improvement in the therapeutic index of chemical compounds (e.g., polyphenols) by: [16][17][18][19][20] (1) increasing their efficacy, (photo-)stability, and solubility, (2) decreasing their potential side effects by leaving the normal sensitive cells unharmed (i.e., reduced toxicity), (3) sustaining their release, (4) increasing their localization to specific tissues, organs, or cells (i.e., enhanced biodistribution), and (5) administering a determined amount directly to the target site (e.g., skinspecific polyphenol delivery), preventing them from circulating until their half-life finishes (i.e., increased bioavailability and pharmacokinetics).

    Although one possible way to overcome the problems of bioavailability (e.g., low solubility, low gut absorption) and toxicity (e.g., side effects of high or accumulated dose of polyphenols) related to several dietary polyphenols to prevent or treat skin conditions might be the use of topically applied delivery of nano-polyphenols, bioavailability studies of topically applied (nano-) polyphenols (e.g., as dermo-therapeutics or cosmeceutics) are still needed. [21] Indeed, compared with the effects of polyphenols in vitro, the significant effects of (nano-) polyphenols in vivo are still limited (e.g., poor design of the in vivo experiments, lack of validated in vivo biomarkers, lack of longitudinal studies, lack of effective bioavailability studies). [3][4][5] Also, one should bear in mind that not all polyphenols can be topically applied to the skin for prevention, protection or repair. Indeed, some of the polyphenols need to be metabolized in the gut in order to become active. [22] Thus, in this case, only active polyphenol-derived metabolites shall be applied, either in their bulk form or, preferentially, in their nano-form. The widely variable metabolism of polyphenols in the skin has been reviewed, showing that beneficial (e.g., anti-inflammatory) or deleterious (e.g., pro-inflammatory) effects could appear, [23] prompting caution in the choice of a given polyphenol when preventing or treating a skin condition.

    Considering our current knowledge on certain polyphenols, the biological effects of transdermal delivery of polyphenols, whatever the considered form (i.e., bulk- or nano-), might then vary according to the following—but not limited to—important parameters: (1) the nature of the polyphenols or active polyphenolderived metabolites (e.g., structure, physical-chemical properties which would influence their adsorption), (2) the purity and dose of those polyphenols, (3) the polyphenolic matrix (e.g., blends such as seen in creams, sprays), (4) the applied duration and dose, (5) the inter-individual skin capacity to absorb the polyphenolic product and to keep it active (i.e., individual sensitivity), and (6) the nature of the system (e.g., type and purity of nano-materials) used to deliver either a given polyphenol, a polyphenol-enriched extract, or a polyphenol-enriched blend of other constituents such as pigments (e.g., carotenoids), vitamins (e.g., ascorbic acid aka vitamin C, α-tocopherol aka vitamin E), or oligo-elements (e.g., selenium and zinc).

    Albeit an increasing number of studies using topical application of certain polyphenols in their free forms have been reported, there is undeniably a paucity of reports regarding the design, development and application of polyphenol nano-formulations for skin care and engineering.

    2. Skin Applications of Polyphenols in their Bulk Form

    2.1. Polyphenols and Potential Skin Health Benefits

    Polyphenols and derivatives (e.g., curcumin aka diferuloylmethane, apigenin, quercetin, ursolic acid, resveratrol, EGCG) are known to display antitumor, anti-inflammatory, antiviral, antibacterial, insecticidal, apoptotic, anti-aging, and antioxidant properties. [3][24][25][26][27][28][29][30][31]

    Besides, in conjunction with chemo-therapeutics (e.g., B-RAF mutant inhibitors in the case of metastatic melanoma), cosmetics (e.g., sunscreens), or esthetic techniques for skin rejuvenation (e.g., non-ablative intense pulsed light/laser (IPL), microdermabrasion), topical polyphenols can create synergy and optimize clinical outcomes. [3][32][33][34] For instance, in reports supporting the use of multi-modal therapy for nonablative facial skin rejuvenation, it has been shown that the concurrent pneumatic topical application of polyphenolic antioxidants on IPL-treated human skin reduced IPL-induced: [33][34] (1) inflammation (e.g., erythema), (2) oxidative stress (e.g., increased lipid peroxidation), (3) dehydration (e.g., increase of skin moisture content), and (4) hyper-pigmentation; epidermal and papillary dermal thinness.

    Currently, most of the studies for topical skin application of polyphenols have been performed mainly using tea-derived polyphenols (e.g., EGCG), in animal models (e.g., SKH-1 hairless, Sencar, BALB/c, and C3H/HeN mice) and/or skin cells (e.g., fibroblasts, keratinocytes). [3][24][25][30][35][36][37][38][39][40][41][42][43] Nevertheless, it is noteworthy that there is still a lack of large (>50 individuals), international, randomized, controlled, and longitudinal (>12 weeks) clinical studies in humans. [3]

    2.2. Tea-Derived Polyphenols: A Key Reference for Skin Applications

    Previous research studies led in mice showed beneficial inhibitory effects of topically applied black teatheaflavins (e.g., theaflavin-3,30-digallate) or major green tea polyphenols (GTPs) (e.g., EGCG) on chemical tumor promoters (e.g., 12-O-tetradecanoylphorbol-13-acetate (TPA))-induced tumorigenesis, carcinogenesis and inflammatory skin edema (e.g., infiltration of neutrophils, hyperplasia, cyclooxygenase (COX) and ornithine decarboxylase (ODC) activities), providing a good promise for chemoprevention (e.g., decreased occurrence of melanoma and non-melanomas such as squamous cell carcinoma (SCC) and basal cell carcinoma (BCC)). [35][39][42][44][45][46][47][48]

    Further, a number of scientific studies performed in mice and humans exposed to UV-induced DNA damage have provided a molecular mechanistic basis to explain the skin photo-chemopreventive effect (e.g., DNA repair and antioxidant activities, anti-photoinduced immunosuppression such as anti-depletion of antigen-presenting cells) as well as the anti-skin photoaging (e.g., anti-accelerated signs of aging such as wrinkles, improvement in elastic tissue content) of teaderived polyphenols, suggesting that these natural products can also serve as natural alternatives or enhancers to sunscreens. [7][36][46][49][50][51][52][53][54][55][56][57][58][59][60][61][62] For instance, in a study led in SKH-1 hairless mice, 36 topical applications of EGCG resulted in a significant decrease in UVB-induced bifold-skin thickness, skin edema and infiltration of leukocytes by molecular mechanisms involving modulations in mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-κB) signaling pathways such as inhibition of ultraviolet B (UVB)-induced: (1) phosphorylation of extracellularsignal regulated kinases 1/2 (ERK1/2 aka p42/44 MAPK), (2) c-Jun N-terminal kinases (c-JNK), (3) p38 MAPK expression, (4) NF-κB activity, (5) inhibitor of NF-κB kinase-alpha (IKK-κB activity, (6) phosphorylation and degradation of the inhibitor of NF-κB-alpha (Ikβ-α aka nuclear factor of kappa light polypeptide gene enhancer in the B-cell inhibitor, α).

    3. Conclution

    Topically applied polyphenols have certain advantages over oral or intravenous administration of these phytochemicals (e.g., lower systemic toxicity usually associated with required increased doses to reach a specific tissue). Further, therapeutic uses of nanotechnology involving naturally occurring polyphenols are proving advanced pharmacological effects (e.g., efficacy, safety, selectivity) compared to the therapeutic entities they contain. Active intracellular delivery and improved pharmacokinetics and pharmacodynamics of polyphenol-containing nanoparticles depend on various factors, including their size and surface properties. Topically polyphenols containing nano-particles, alone or as "adjuvants" (nano-)therapeutics/cosmeceutics, is an emerging and promising treatment modality not only in oncology (e.g., prevention, protection and treatment of melanoma or non-melanoma skin cancers), but also for treating other inflammatorystate diseases and disorders (e.g., skin infections) and potentially enhancing tissue repair/reconstruction (i.e., wound healing, skin xenograft transplantations, skin reconstruction/regeneration, anti-aging skin). To fully realize this potential, more clinical trials are needed with nano-formulated polyphenols for topical application. Eventually, the fate and the short- or long-term effects (e.g., toxicity) of the nano-carrier materials, used to entrap the polyphenols for topical use, remain to be better understood.

    The entry is from 10.1016/b978-0-12-398456-2.00065-7


    1. Claudine Manach; Augustin Scalbert; Christine Morand; Christian Rémésy; Liliana Jiménez; Polyphenols: food sources and bioavailability. The American Journal of Clinical Nutrition 2004, 79, 727-747, 10.1093/ajcn/79.5.727.
    2. Massimo D'archivio; Carmela Filesi; Roberta Di Benedetto; Raffaella Gargiulo; Claudio Giovannini; Roberta Masella; Polyphenols, dietary sources and bioavailability.. Annali dell'Istituto Superiore di Sanità 2007, 43, 348-361, .
    3. Farid Menaa; Abder Menaa; Jacques Tréton; Polyphenols against Skin Aging. Polyphenols in Human Health and Disease 2014, 1, 819-830, 10.1016/b978-0-12-398456-2.00063-3.
    4. Claudine Manach; Gary Williamson; Christine Morand; Augustin Scalbert; Christian Rémésy; Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition 2005, 81, 230S-242S, 10.1093/ajcn/81.1.230s.
    5. G. Williamson; Claudine Manach; Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. The American Journal of Clinical Nutrition 2005, 81, 243S-255S, 10.1093/ajcn/81.1.243s.
    6. Scholz; Gary Williamson; Interactions Affecting the Bioavailability of Dietary Polyphenols in Vivo. International Journal for Vitamin and Nutrition Research 2007, 77, 224-235, 10.1024/0300-9831.77.3.224.
    7. Joi A. Nichols; Santosh K. Katiyar; Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Archives of Dermatological Research 2009, 302, 71-83, 10.1007/s00403-009-1001-3.
    8. Daniele Del Rio; L.G. Costa; M.E.J. Lean; A. Crozier; Polyphenols and health: What compounds are involved?. Nutrition, Metabolism and Cardiovascular Diseases 2010, 20, 1-6, 10.1016/j.numecd.2009.05.015.
    9. P. Morganti; C. Bruno; F. Guarneri; A. Cardillo; P. Del Ciotto; F. Valenzano; Role of topical and nutritional supplement to modify the oxidative stress*. International Journal of Cosmetic Science 2002, 24, 331-339, 10.1046/j.1467-2494.2002.00159.x.
    10. Sheldon R. Pinnell; Cutaneous photodamage, oxidative stress, and topical antioxidant protection. Journal of the American Academy of Dermatology 2003, 48, 1-22, 10.1067/mjd.2003.16.
    11. Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA, et al.; Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechingallate and polyphenon E in healthy individuals. Clin. Cancer Res. 2003, 9, 3312-3319, .
    12. Gerben A. Koning; Targeted Multifunctional Lipid-Based Nanocarriers for Image-Guided Drug Delivery. Anti-Cancer Agents in Medicinal Chemistry 2007, 7, 425-440, 10.2174/187152007781058613.
    13. Hareesh B. Nair; Bokyung Sung; Vivek R. Yadav; Ramaswamy Kannappan; Madan M. Chaturvedi; Bharat B. Aggarwal; Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochemical Pharmacology 2010, 80, 1833-1843, 10.1016/j.bcp.2010.07.021.
    14. Shaker A. Mousa; Dhruba J. Bharali; Nald Armstrong; From nutraceuticals to pharmaceuticals to nanopharmaceuticals: a case study in angiogenesis modulation during oxidative stress.. Molecular Biotechnology 2007, 37, 72-80, 10.1007/s12033-007-0064-7.
    15. Mark E. Davis; Zhuo (Georgia) Chen; Dong M. Shin; Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature Reviews Drug Discovery 2008, 7, 771-782, 10.1038/nrd2614.
    16. Qingrong Huang; Hailong Yu; Qiaomei Ru; Bioavailability and Delivery of Nutraceuticals Using Nanotechnology. Journal of Food Science 2010, 75, R50-R57, 10.1111/j.1750-3841.2009.01457.x.
    17. Elaine M. Merisko-Liversidge; Gary G. Liversidge; Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds. Toxicologic Pathology 2008, 36, 43-48, 10.1177/0192623307310946.
    18. Volker Wagner; Anwyn Dullaart; Anne-Katrin Bock; Axel Zweck; The emerging nanomedicine landscape. Nature Biotechnology 2006, 24, 1211-1217, 10.1038/nbt1006-1211.
    19. Kristina Riehemann; Stefan W. Schneider; Thomas A. Luger; Biana Godin; Mauro Ferrari; Harald Fuchs; Nanomedicine-Challenge and Perspectives. Angewandte Chemie International Edition 2009, 48, 872-897, 10.1002/anie.200802585.
    20. Mauro Ferrari; Cancer nanotechnology: opportunities and challenges. Nature Reviews Cancer 2005, 5, 161-171, 10.1038/nrc1566.
    21. Howard Epstein; Cosmeceuticals and polyphenols. Clinics in Dermatology 2009, 27, 475-478, 10.1016/j.clindermatol.2009.05.011.
    22. Myriam Myriam; Magalie Sabatier; Heike Steiling; Gary Williamson; Skin bioavailability of dietary vitamin E, carotenoids, polyphenols, vitamin C, zinc and selenium. British Journal of Nutrition 2006, 96, 227-238, 10.1079/bjn20061817.
    23. Liudmila Korkina; Saveria Pastore; Chiara De Luca; Vladimir A. Kostyuk; Metabolism of Plant Polyphenols in the Skin: Beneficial Versus Deleterious Effects. Current Drug Metabolism 2008, 9, 710-729, 10.2174/138920008786049267.
    24. Menaa F., Badole S.L., Menaa B., Menaa A., Bodhankar S.L.. Polyphenols: promising therapeutics for inflammatory disease?; Watson R.R., Preedy V.R., Eds.; Academic Press: San Diego, CA, USA, 2013; pp. 421-430.
    25. Zanwar A.A., Badole L.S., Menaa F.. Curcuma longa: use for skin disease care; Watson R.R., Zibadi S., Eds.; Springer: New York, 2013; pp. 391-396.
    26. Preetha Anand; Chitra Sundaram; Sonia Jhurani; Ajaikumar B. Kunnumakkara; Bharat B. Aggarwal; Curcumin and cancer: An “old-age” disease with an “age-old” solution. Cancer Letters 2008, 267, 133-164, 10.1016/j.canlet.2008.03.025.
    27. Jie Yang; Lin Li; Suiyi Tan; Hong Jin; Jiayin Qiu; Qinchao Mao; Runming Li; Chenglai Xia; Zhi-Hong Jiang; Shibo Jiang; et al. A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: Potential applications for preventing HIV-1 infection. Fitoterapia 2012, 83, 348-355, 10.1016/j.fitote.2011.11.016.
    28. Lisbeth A. Pacheco-Palencia; Giuliana D. Noratto; Lal Hingorani; Stephen T. Talcott; Susanne U. Mertens-Talcott; Protective Effects of Standardized Pomegranate (Punica granatumL.) Polyphenolic Extract in Ultraviolet-Irradiated Human Skin Fibroblasts. Journal of Agricultural and Food Chemistry 2008, 56, 8434-8441, 10.1021/jf8005307.
    29. Simone Duarte; Stacy Gregoire; Ajay P. Singh; Nicholi Vorsa; Karen Schaich; William H. Bowen; H. Koo; Inhibitory effects of cranberry polyphenols on formation and acidogenicity ofStreptococcus mutansbiofilms. FEMS Microbiology Letters 2006, 257, 50-56, 10.1111/j.1574-6968.2006.00147.x.
    30. Hsu S.; Green tea and the skin. J. Am. Acad. Dermatol. 2005, 52, 1049-1059, .
    31. M S Hashim; K S Devi; Insecticidal action of the polyphenolic rich fractions from the stem bark of Streblus asper on Dysdercus cingulatus.. Fitoterapia 2003, 74, 670-676, 10.1016/s0367-326x(03)00186-2.
    32. Farid Menaa; Latest Approved Therapies for Metastatic Melanoma: What Comes Next?. Journal of Skin Cancer 2013, 2013, 1-10, 10.1155/2013/735282.
    33. Bruce M. Freedman; Topical polyphenolic antioxidants reduce the adverse effects of intense pulsed light therapy.. Journal of Cosmetic and Laser Therapy 2009, 11, 142-145, 10.1080/14764170902984887.
    34. Bruce M. Freedman; Topical antioxidant application augments the effects of intense pulsed light therapy. Journal of Cosmetic Dermatology 2009, 8, 254-259, 10.1111/j.1473-2165.2009.00461.x.
    35. Liang Y.C., Tsai D.C., Lin-Shiau S.Y., Chen C.F., Ho C.T., Lin J.K.; Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced inflammatory skin edema and ornithine decarboxylase activity by theaflavin-3,30-digallate in mouse. Nutr. Cancer 2002, 42, 217-223, .
    36. Farrukh Afaq; Nihal Ahmad; Hasan Mukhtar; Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene 2003, 22, 9254-9264, 10.1038/sj.onc.1207035.
    37. Tetsuya Yamamoto; Stephen Hsu; Jill Lewis; John Wataha; Douglas Dickinson; Baldev Singh; Wendy B. Bollag; Petra Lockwood; Eisaku Ueta; Tokio Osaki; et al. Green Tea Polyphenol Causes Differential Oxidative Environments in Tumor versus Normal Epithelial Cells. Journal of Pharmacology and Experimental Therapeutics 2003, 307, 230-236, 10.1124/jpet.103.054676.
    38. Hirota Fujiki; Masami Suganuma; Sachiko Okabe; Eisaburo Sueoka; Kenji Suga; Kazue Imai; Kei Nakachi; Shunsaku Kimura; Mechanistic Findings of Green Tea as Cancer Preventive for Humans. Proceedings of the Society for Experimental Biology and Medicine 1999, 220, 225-228, 10.1046/j.1525-1373.1999.d01-38.x.
    39. Santosh K. Katiyar; Rajesh Agarwal; Susan Ekker; Gary S. Wood; Hasan Mukhtar; Protection against 12-O-tetradecanoylphorbol-13-acetate-caused inflammation in SENCAR mouse ear skin by polyphenolic fraction isolated from green tea. Carcinogenesis 1993, 14, 361-365, 10.1093/carcin/14.3.361.
    40. H U Gali; E M Perchellet; J P Perchellet; Inhibition of tumor promoter-induced ornithine decarboxylase activity by tannic acid and other polyphenols in mouse epidermis in vivo.. Cancer Research 1991, 51, 2820-2825, .
    41. Zhi Y. Wang; Wasiuddin A. Khan; David R. Bickers; Hasan Mukhtar; Protection against polycyclic aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols. Carcinogenesis 1989, 10, 411-415, 10.1093/carcin/10.2.411.
    42. W.A. Khan; Z.Y. Wang; M. Athar; D.R. Bickers; H. Mukhtar; Inhibition of the skin tumorigenicity of (±)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Sencar mice. Cancer Letters 1988, 42, 7-12, 10.1016/0304-3835(88)90232-7.
    43. Menaa F., Menaa A.. Skin photoprotection by polyphenols in animal models and humans; Watson R.R., Preedy V.R., Zibadi S., Eds.; Academic Press: Amsterdam, Netherlands, 2014; pp. 831-838.
    44. S Javed; N K Mehrotra; Y Shukla; Chemopreventive effects of black tea polyphenols in mouse skin model of carcinogenesis.. Biomedical and Environmental Sciences 1998, 11, 307-313, .
    45. S K Katiyar; H Mukhtar; Inhibition of phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate-caused inflammatory responses in SENCAR mouse skin by black tea polyphenols.. Carcinogenesis 1997, 18, 1911-1916, 10.1093/carcin/18.10.1911.
    46. S K Katiyar; R R Mohan; R Agarwal; H Mukhtar; Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols.. Carcinogenesis 1997, 18, 497-502, .
    47. Hasan Mukhtar; Santosh K. Katiyar; Rajesh Agarwal; Green Tea and Skin—Anticarcinogenic Effects. Journal of Investigative Dermatology 1994, 102, 3-7, 10.1111/1523-1747.ep12371720.
    48. Farrukh Afaq; Polyphenols: Skin Photoprotection and Inhibition of Photocarcinogenesis. Mini-Reviews in Medicinal Chemistry 2011, 11, 1200-1215, 10.2174/13895575111091200.
    49. Santosh K. Katiyar; Green tea prevents non-melanoma skin cancer by enhancing DNA repair. Archives of Biochemistry and Biophysics 2011, 508, 152-158, 10.1016/
    50. Melissa M. Camouse; Diana Santo Domingo; Freddie R. Swain; Edward P. Conrad; Mary S. Matsui; Daniel Maes; Lieve Declercq; Kevin D. Cooper; Seth R. Stevens; Elma D. Baron; et al. Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin. Experimental Dermatology 2009, 18, 522-526, 10.1111/j.1600-0625.2008.00818.x.
    51. Kenneth G. Linden; Philip M Carpenter; Christine E McLaren; Ronald J Barr; Pamela Hite; Joannie D Sun; Kou-Tung Li; Jaye L Viner; Frank L Meyskens; Chemoprevention of nonmelanoma skin cancer: experience with a polyphenol from green tea.. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 2003, 163, 165-171, .
    52. Praveen K Vayalil; Craig A Elmets; Santosh K. Katiyar; Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin.. Carcinogenesis 2003, 24, 927-936, 10.1093/carcin/bgg025.
    53. Santosh K. Katiyar; H Mukhtar; Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress.. Journal of Leukocyte Biology 2001, 69, 719-726, .
    54. Craig A. Elmets; Divya Singh; Karen Tubesing; Mary Matsui; Santosh Katiyar; Hasan Mukhtar; Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. Journal of the American Academy of Dermatology 2001, 44, 425-432, 10.1067/mjd.2001.112919.
    55. Santosh K. Katiyar; Craig A. Elmets; Rajesh Agarwal; Hasan Mukhtar; PROTECTION AGAINST ULTRAVIOLET-B RADIATION-INDUCED LOCAL and SYSTEMIC SUPPRESSION OF CONTACT HYPERSENSITIVITY and EDEMA RESPONSES IN C3H/HeN MICE BY GREEN TEA POLYPHENOLS. Photochemistry and Photobiology 2008, 62, 855-861, 10.1111/j.1751-1097.1995.tb09147.x.
    56. S K Katiyar; R Agarwal; H Mukhtar; Inhibition of both stage I and stage II skin tumor promotion in SENCAR mice by a polyphenolic fraction isolated from green tea: inhibition depends on the duration of polyphenol treatment.. Carcinogenesis 1993, 14, 2641-2643, .
    57. Murat Turkoglu; T Uğurlu; G Gedik; A M Yılmaz; A. Süha Yalçın; In vivo evaluation of black and green tea dermal products against UV radiation.. Drug Discoveries & Therapeutics 2010, 4, 262-267, .
    58. Navid Bouzari; Yvonne Romagosa; Robert S. Kirsner; Green Tea Prevents Skin Cancer by Two Mechanisms. Journal of Investigative Dermatology 2009, 129, 1054-1054, 10.1038/jid.2009.64.
    59. Korkina L.G., Pastore S., Dellambra E., De Luca C.; New molecular and cellular targets for chemoprevention and treatment of skin tumours by plant polyphenols: a critical review. Curr. Med. Chem. 2013, 20, 852-868, .
    60. Annie E. Chiu; Joanna L. Chan Ab; Dale G. Kern; Sabine Kohler; Wingfield E. Rehmus; Alexa B. Kimball; Double-Blinded, Placebo-Controlled Trial of Green Tea Extracts in the Clinical and Histologic Appearance of Photoaging Skin. Dermatologic Surgery 2006, 31, 855-860, 10.1111/j.1524-4725.2005.31731.
    61. Santosh Katiyar; Craig Elmets; Green tea polyphenolic antioxidants and skin photoprotection (Review). International Journal of Oncology 2001, 18, 1307-1313, 10.3892/ijo.18.6.1307.
    62. L. Korkina; Chiara De Luca; Vladimir A. Kostyuk; S. Pastore; Plant Polyphenols and Tumors: From Mechanisms to Therapies, Prevention, and Protection Against Toxicity of Anti-Cancer Treatments. Current Medicinal Chemistry 2009, 16, 3943-3965, 10.2174/092986709789352312.